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Summary
Background In many cells, depletion of intracellular calcium (Ca
2+) reservoirs trig-
gers Ca
2+ entry through store-operated Ca
2+ channels in the plasma membrane.
However, the mechanisms of agonist-induced calcium entry (ACE) in keratino-
cytes are not fully understood.
Objectives This study was designed to determine if pharmacological inhibition of
calcium-independent phospholipase A (iPLA2) impairs ACE in normal human
epidermal keratinocytes.
Methods Confocal laser scanning microscopy was used to monitor the dynamics of
Ca
2+ signalling in keratinocytes loaded with the calcium-sensitive dye Fluo-4.
Cells were stimulated with extracellular nucleotides [adenosine triphosphate
(ATP) or uridine triphosphate (UTP)] or with lysophosphatidic acid (LPA), a
bioactive lipid that regulates keratinocyte proliferation and differentiation.
Results Both ATP and UTP induced Ca
2+ release in primary human keratinocytes.
This was not followed by robust Ca
2+ inﬂux when the experiments were performed
in low Ca
2+ (70 lmol L
)1) medium. Upon elevation of extracellular Ca
2+ to
1Æ2 mmol L
)1, however, a biphasic response consisting of an initial Ca
2+ peak fol-
lowed by an elevated plateau was observed. The plateau phase was inhibited when
cells were treated with bromoenol lactone, a speciﬁc pharmacological inhibitor of
iPLA2. These ﬁndings indicate that iPLA2 activity is required for ACE in keratino-
cytes. LPA also evoked Ca
2+ release in keratinocytes but failed to induce sustained
Ca
2+ entry even when extracellular Ca
2+ was elevated to 1Æ2 mmol L
)1.
Conclusion Our results demonstrate for the ﬁrst time an important role for iPLA2 in
regulating ACE in primary human keratinocytes.
Calcium is a ubiquitous second messenger that regulates
numerous cellular processes such as gene transcription, cell pro-
liferation, exocytosis and contraction.
1 Free cytosolic calcium
([Ca
2+]i) levels are tightly controlled by a complex network of
receptors, channels and pumps located in the plasma membrane
(PM) and on intracellular organelles such as the endoplasmic
reticulum (ER), mitochondria and the Golgi apparatus. Stimula-
tion of G protein-coupled receptors (GPCRs), tyrosine kinase
receptors and nonreceptor tyrosine kinases activate phospho-
lipase C (PLC) which in turn hydrolyses phosphatidylinositol
4,5-bisphosphate to diacylglycerol and inositol 1,4,5-trisphos-
phate (IP3).
2 Binding of IP3 to its receptors (IP3R) on the ER
triggers the release of Ca
2+ from the ER lumen leading to store
depletion.
1 In many cells, this initial release is followed by a
sustained inﬂux of Ca
2+ across the PM, a phenomenon known
as store-operated calcium entry (SOCE), which is the dominant
form of Ca
2+ entry in nonexcitable cells.
3
One model of SOCE involves a diffusible messenger or ‘cal-
cium inﬂux factor’ (CIF) that is released from the ER upon
store depletion.
4 Although the identity of CIF is unknown, it
appears to be a soluble factor of 600 Da that activates cal-
cium-independent phospholipase A (iPLA2) by displacement
of inhibitory calmodulin (CaM) from iPLA2.
5 This leads to the
production of lysophospholipids (lysoPLs) and free fatty acid.
The lysoPLs, such as lysophosphatidylcholine, then activate
SOCE at the PM by an uncharacterized process. Thus iPLA2
activity appears to be required for SOCE.
A second model for SOCE has emerged recently, involving
STIM1 and Orai1. STIM1, a Ca
2+-sensing protein localized
predominantly to the ER contains a low-afﬁnity Ca
2+-binding
EF hand which resides in the ER lumen when the stores are
full. Depletion of the stores by IP3-mediated Ca
2+ release,
or by inhibition of the sarco-endoplasmic reticulum Ca
2+-
ATPase (SERCA) pump with thapsigargin (TG) causes Ca
2+ to
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into discrete puncta.
6,7 These complexes appear to associate
with, and activate, the transmembrane protein Orai1, which
appears to be the pore through which SOCE occurs.
8–12 Inter-
estingly, STIM1 has also been reported to activate TRPC1,
13,14
a member of the transient receptor potential (TRP) family of
proteins which have been implicated in cation entry.
15
Little is known about the mechanisms of Ca
2+ entry in
keratinocytes. A requirement for PLCc for SOCE has been
demonstrated,
16 along with the formation of a ternary com-
plex composed of PLCc, TRPC1 and IP3R. However, the puta-
tive role of iPLA2 in Ca
2+ entry in keratinocytes has not been
examined. In the present study therefore, we have investigated
the role of iPLA2 in agonist-induced Ca
2+ entry (ACE) in
normal human epidermal keratinocytes (NHEKs). We have
performed our studies using physiological agonists such as
adenosine triphosphate (ATP) and uridine triphosphate (UTP),
which have been reported to promote NHEK proliferation
in vitro
17,18 and lysophosphatidic acid (LPA, 1-acyl-sn-glycerol-
3-phosphate), which can promote proliferation or differentia-
tion depending on cell density.
19 These agonists are released
by platelets recruited to the epidermis following injury,
17,20
indicating a role in epidermal homeostasis. We found that the
extracellular nucleotides but not LPA evoked sustained ACE in
NHEK and that this was mediated at least in part by iPLA2.
Materials and methods
Reagents
Fluo-4-AM was purchased from Molecular Probes (Eugene,
OR, U.S.A.), bromoenol lactone (BEL) from Sigma (Poole,
Dorset, U.K.) and the iPLA2 antibody from Santa Cruz (Santa
Cruz, CA, U.S.A.). The iPLA2 antibody recognizes iPLA2b but
not iPLA2c according to the manufacturer. All other reagents
were obtained from Sigma unless stated otherwise.
Cell culture
NHEK were prepared from redundant foreskin with the
approval of the Newcastle and North Tyneside local ethical com-
mittee. The cells were cultured in supplemented MCDB 153 cul-
ture medium as previously described.
21 For imaging, cells were
seeded at passage 1 or 2 in 20 lL suspensions containing
10 000–20 000 cells, with the medium increased to 1 mL
about 45 min to 1 h after seeding.
Calcium imaging
Subconﬂuent monolayers of cells, seeded in Willco glass-bot-
tomed microwell dishes (Intracel, Royston, U.K.) 1 day before
experiments, were loaded with 3 lmol L
)1 of Fluo-4 acet-
oxymethyl (AM) ester (Molecular Probes) for 45 min at
37  C. Dye loading and all subsequent steps were performed
with MCDB153 medium (Sigma) containing 70 lmol L
)1
Ca
2+ unless indicated otherwise. To minimize uptake of the
dye into organelles, 200 lmol L
)1 of the anion transport
inhibitor sulphinpyrazone was dissolved in dimethyl sulphox-
ide (DMSO) and included in the medium during loading and
de-esteriﬁcation. After loading, the cells were washed in Ca
2+
and Mg
2+ free phosphate-buffered saline (PBS) and incubated
in MCDB 153 medium with 70 lmol L
)1 Ca
2+ for 1 h at
37  C to allow de-esteriﬁcation of the intracellular dye. Where
indicated, Ca
2+ in the medium was raised to 1Æ2 mmol L
)1 at
the start of the de-esteriﬁcation phase. The iPLA2 inhibitor BEL
(10 or 20 lmol L
)1) or vehicle (0Æ1% DMSO) was added for
the last 30 min of de-esteriﬁcation.
The cells were maintained at 37  C during image acquisition
with a heated stage. Changes in [Ca
2+]i were detected with a
Leica TCS SP2 confocal laser scanning microscope equipped
with an argon laser (Leica, Milton Keynes, U.K.). Fluorescence
excitation was performed with the 488 nm line of the laser.
Fluorescence emission was collected through a 500–550 nm
window of the detector. Images were captured with a 63X
Plan Apo objective (NA1.32) at 4-s intervals as 12-bit frames
of 512 · 512 pixels. The perimeter of each cell was outlined
to deﬁne the region of interest whose mean ﬂuorescence in-
tensity in each frame was determined by Leica confocal soft-
ware. The changes in [Ca
2+]i were expressed as the ratio of
the temporal ﬂuorescence to the initial ﬂuorescence (Ft⁄F0).
Western blotting
Primary keratinocyte lysates were separated on a 10% Bis-Tris
gel (Invitrogen, Paisley, U.K.), transferred to a nitrocellulose
membrane and incubated overnight with 10 lgm L
)1 of iPLA2
antibody (goat polyclonal, Santa Cruz). After extensive wash-
ing the membrane was probed with a biotinylated secondary
antibody for 2–3 h, processed for chemiluminescence using
ABC reagents (Vector Laboratories, Burlingame, CA, U.S.A.)
and ECL Advance
TM (GE Healthcare, Little Chalfont, U.K.),
then visualized on a phosphoimager.
Statistical analysis
Results of the Ca
2+ imaging experiments are presented as means
(± SEM) which were determined in GraphPad Prism (GraphPad
Software, San Diego, CA, U.S.A.) or Microsoft Excel. Statistical
signiﬁcance was calculated using the unpaired two-tailed
Student’s t-test. A P-value < 0Æ05 was considered signiﬁcant.
Results
Agonist-induced Ca
2+ entry in primary keratinocytes
Several studies have shown that ATP and UTP evoke [Ca
2+]i
elevation in primary keratinocytes,
17,22 but the extent to
which this promotes a sustained increase in [Ca
2+]i (indicative
of Ca
2+entry) was not clear. When preconﬂuent monolayers
of NHEKs were stimulated with UTP, a single [Ca
2+]i transient
was observed in the majority of responsive cells (Fig. 1a,b).
The rise in [Ca
2+]i began immediately following the addition
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entire [Ca
2+]i signal lasted just over 2 min before returning to
baseline levels. In 6% (6 of 98 responsive cells from four
experiments), a second transient of smaller amplitude was
observed at later time points (Fig. 1d). Stimulation of the cells
with ATP also induced a single 2 min [Ca
2+]i transient in
most of the responsive cells (Fig. 1c), with a second [Ca
2+]i
peak in 23% of the cell population (16 of 70 responsive cells
pooled from ﬁve experiments; Fig. 1e).
In these experiments, which were performed in medium
containing 70 lmol L
)1 Ca
2+ we consistently failed to observe
sustained [Ca
2+]i elevation. We therefore repeated the assays
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Fig 1. Ca
2+ mobilization in normal human epidermal keratinocytes (NHEKs) following uridine triphosphate (UTP) or adenosine triphosphate
(ATP) stimulation. (a) Pseudocolour confocal micrographs of NHEKs loaded with Fluo-4 and stimulated with 10 lmol L
)1 UTP. The images
shown are for t = 20 s (that is, just prior to addition of the agonist), t = 28 s and t = 40 s. Scale bar, 47 lm. (b,c) Averaged changes in Fluo-4
intensity following stimulation of NHEKs in medium containing 70 lmol L
)1 calcium with 10 lmol L
)1 UTP or ATP. The agonists were added
20 s after the start of recording, as indicated by the arrow. The data shown for each agonist were pooled from three independent experiments
(cell preparations from three independent donors), with n = 59 cells and n = 32 cells for (b) and (c), respectively. For clarity, only selected error
bars are shown. Error bars = SEM. (d,e) Representative traces from cells in which a second [Ca
2+]i peak was observed after the initial peak evoked
by UTP (d) or ATP (e) stimulation.
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)1 [Ca
2+]o
for ~1 h. Over several hours 1 mmol L
)1 extracellular calcium
itself stimulates a signiﬁcant rise in [Ca
2+]i and promotes dif-
ferentiation.
23 Both UTP and ATP induced a biphasic response
under these conditions, with a deﬁned initial peak followed
by an elevated plateau indicative of Ca
2+entry (Fig. 2a,b).
Taken together, these results indicate that the extracellular cal-
cium ([Ca
2+]o) level needs to be in the millimolar range
before the electrochemical gradient is sufﬁciently high to pro-
mote robust ACE in keratinocytes following stimulation with
exogenous nucleotides.
Inhibition of iPLA2 impairs agonist-induced calcium entry
in primary keratinocytes
A recent study by Bolotina and co-workers showed that phar-
macological inhibition or RNAi knockdown of iPLA2
impaired TG-induced entry in mouse smooth muscle cells.
4
Although the TG-induced SOCE has historically been consid-
ered as a mechanistic parallel of ACE, differences are begin-
ning to emerge.
24,25 Thus, we asked if iPLA2 activity was
required for ACE in NHEKs. For these studies, we used the
suicide substrate, BEL, to inhibit iPLA2 activity. BEL is a spe-
ciﬁc inhibitor of iPLA2, with a 1000-fold selectivity for iPLA2
over cytosolic PLA2.
26 Paired assays were performed on kerat-
inocytes from the same donors. As shown in Figure 3, stim-
ulation with UTP in the presence of 1Æ2 mmol L
)1 [Ca
2+]o
led to a sustained [Ca
2+]i plateau in control cells exposed to
vehicle (DMSO), consistent with the results shown in
Figure 2a. In contrast, the elevated [Ca
2+]i phase was
impaired in cells treated with BEL (Fig. 3a), returning to
baseline by 300 s in contrast to control cells. It is important
to note that the control cells in Figure 3a were treated with
dimethylsulphoxide which might explain why their responses
differed somewhat to those in Figure 2a. Nevertheless, the
data suggest that BEL treatment impairs Ca
2+entry in NHEK.
Furthermore, similar results were obtained on the HaCaT
keratinocyte cell line.
39 The expression of iPLA2 in NHEK
was assessed by Western blotting (Fig. 3c). An 85-kDa band
corresponding to the expected size of iPLA2 was speciﬁcally
detected in NHEK lysates probed with an antibody against
iPLA2 conﬁrming that iPLA2 is expressed in these cells.
LPA-induced [Ca
2+]i signalling in keratinocytes
Intracellular Ca
2+ release by UTP and ATP is mediated by
the P2Y family of GPCRs.
18 To determine if stimulation of
a different class of PLCb-activating GPCRs also evoked ACE
in keratinocytes, we examined the [Ca
2+]i dynamics induced
by LPA. This bioactive phospholipid has been shown to
modulate keratinocyte growth and differentiation
19 and sig-
nals through members of the LPA1–3 family of GPCRs. In
NHEK maintained in medium containing 70 lmol L
)1
[Ca
2+]o, LPA (10 lmol L
)1) evoked a single [Ca
2+]i tran-
sient that reached a peak about 20 s thereafter (Fig. 4a).
The peak [Ca
2+]i signal persisted for about 30 s before
starting to decline to resting levels. Overall the transient
lasted for about 4 min, signiﬁcantly longer than that
observed with extracellular nucleotides. We then asked if
elevation of [Ca
2+]o to 1Æ2 mmol L
)1 would facilitate the
induction of an elevated [Ca
2+]i plateau following LPA stim-
ulation. In contrast to ATP and UTP, the LPA-induced
[Ca
2+]i transient produced under these conditions was not
generally followed by a [Ca
2+]i plateau (Fig. 4b). This
result also controls against the possibility that raised
(1Æ2 mmol L
)1) [Ca
2+]o was exerting a nonspeciﬁc effect
enhancing effect on ACE in keratinocytes. In addition, the
duration of the transient was not signiﬁcantly altered by the
inclusion of 10 mmol L
)1 EGTA in the medium, indicating
that sustained Ca
2+ entry did not occur (data not shown).
Thus LPA does not appear to induce signiﬁcant Ca
2+ inﬂux
in keratinocytes. This observation is consistent with the
ﬁndings of others on T cells and ﬁbroblasts.
27,28 The inabil-
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Fig 2. Agonist-induced calcium entry (ACE) in normal human
epidermal keratinocytes (NHEKs) occurs upon elevation of
extracellular Ca
2+. NHEKs were switched to MCDB 153 medium
containing 1Æ2 mmol L
)1 Ca
2+ for at least 1 h and stimulated with
10 lmol L
)1 of each agonist as indicated. Averaged time courses of
the [Ca
2+]i signal for (a) UTP (n = 23 cells) and (b) ATP (n =2 4
cells). Data shown are representative of at least three independent
experiments (cell preparations from three independent donors), that
gave similar results. For clarity, only selected error bars are shown.
Error bars = SEM.
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34 Role of iPLA2 in agonist-induced calcium entry, K. Ross et al.ity of LPA to evoke ACE in our experiments was not due
to submaximal stimulation because dose–response curves
revealed that LPA-mediated Ca
2+ release peaked at about
1 lmol L
)1 (Fig. 4c). Furthermore, LPA was a more potent
inducer of Ca
2+ release than UTP, with an EC50 of
40 nmol L
)1 compared with 265 nmol L
)1 for UTP.
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Fig 3. Inhibition of iPLA2 impairs agonist-induced calcium entry (ACE)
in normal human epidermal keratinocytes (NHEKs). (a) Extracellular
calcium was raised to 1Æ2 mmol L
)1 for at least 1 h before image
acquisition. Changes in the Ft ⁄F0 ratio averaged from paired assays on
NHEKs treated with the iPLA2 inhibitor bromoenol lactone (BEL) for
30 min (ﬁlled circles, n = 8), or with vehicle (DMSO, open circles,
n = 18) prior to stimulation with 10 lmol L
)1 uridine triphosphate
(UTP). Representative data are from three independent experiments
(cell preparations from three independent donors). (b) Summary data
for abrogation of UTP-induced Ca
2+ entry following inhibition of
iPLA2. Data were pooled from three independent experiments that gave
similar results. Plateau phases were averaged over 100 s in each case.
DMSO, n = 54 cells; BEL, n = 63 cells. Error bars = SEM. (c) Western
blotting conﬁrmed the presence of iPLA2 in NHEK. An 85-kDa band
corresponding to iPLA2 was detected in lysates from untreated (lane 1),
lithium-treated (10 mmol L
)1, 2 days; lane 2) and calcium-treated
(1Æ5 mmol L
)1, 2 days; lane 3) NHEKs probed with an antibody
against iPLA2 (left panel). No band was seen if the iPLA2 antibody was
excluded from the assay (right panel).
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Fig 4. Lysophosphatidic acid (LPA) induces [Ca
2+]i release but not
sustained [Ca
2+]i elevation. Normal human epidermal keratinocytes
(NHEKs) were loaded with Fluo-4 and stimulated with 10 lmol L
)1
LPA 20 s after the start of recording, as indicated by the arrow.
(a) Averaged changes in Fluo-4 intensity following LPA stimulation
(n = 94 cells). Data were pooled from three independent
experiments (cell preparations from three independent donors).
(b) Extracellular calcium was raised to 1Æ2 mmol L
)1 for 1 h before
stimulation with 10 lmol L
)1 LPA (n = 34 cells). Three independent
experiments gave similar results. (c) Dose–response curves for LPA
and uridine triphosphate (UTP)-induced [Ca
2+]i elevation in NHEKs
at 37  C. The peak of the Ft ⁄F0 ratio attained in each cell was
determined for each concentration of agonist. Results are the
means ± SEM for 19–52 cells.
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Global Ca
2+ signals in a cell can be classiﬁed into brief [Ca
2+]i
transients and sustained [Ca
2+]i elevation driven by Ca
2+entry.
The ﬁndings presented in this study indicate for the ﬁrst time
that iPLA2 activity is required for ACE in human keratinocytes.
Evidence from the Gross laboratory indicates that iPLA2 exists
as a ternary complex with Ca
2+⁄CaM.
29 Displacement of CaM
from this complex leads to activation of iPLA2 which in turn
cleaves phospholipids to generate fatty acids such as arachi-
donic acid and lysoPLs.
5 Bolotina and colleagues recently dem-
onstrated a role for lysoPLs iPLA2 in TG-induced SOCE in
rodent cells.
4 Our results extend their observations by show-
ing that ACE in human keratinocytes also appears to be medi-
ated at least in part by iPLA2.
How does iPLA2 mediate ACE? In the CIF-iPLA2 model of
SOCE, the lysoPLs generated by iPLA2 are postulated to activate
store-operated channels directly.
5 However, a ternary complex
composed of PLCc, TRPC1 and IP3R has been detected in
NHEKs.
16 Although the formation of the complex did not
appear to be dependent on store depletion, knockdown of
PLCc or TRPC1 (and TRPC4) suggested a role in Ca
2+ entry.
Could iPLA2 participate in the formation or localization of this
complex? Recent evidence indicates that PLCc interacts with
the TRPC3 to form a functional intermolecular pleckstrin
homology (PH) domain that binds lipids
30 and that this
enhances surface expression of TRPC3 in HEK293 cells. One
possibility then is that lysoPLs generated by iPLA2 enhance the
localization of TRP proteins to the cell surface of keratinocytes,
and that inhibition of iPLA2 impairs this process. However,
we cannot exclude a role for arachidonic acid generated by
iPLA2 activity, given that it has also been implicated in ACE
31
although this seems to occur only at submaximal agonist con-
centrations. Further investigations will be required to delineate
the respective functions of lysoPLs and arachidonic acid in
Ca
2+ entry in keratinocytes.
Although none of the agonists used in our experiments
induced a sustained [Ca
2+]i plateau in primary keratinocytes
under low (70 lmol L
)1) [Ca
2+]o conditions, the [Ca
2+]i
transient induced by LPA under these conditions was signiﬁ-
cantly longer than that induced by UTP. The duration of a
[Ca
2+]i transient depends on the balance of [Ca
2+]i extrusion
from the cytosol by [Ca
2+]i pumps (such as the plasma
membrane Ca
2+ ATPase, PMCA) and [Ca
2+]i re-entry into the
ER through SERCA pumps. Both PMCA and SERCA activity
may be impaired in NHEK stimulated with LPA, given that
LPA has been shown to induce H2O2 production in HaCaT
keratinocytes
32 and H2O2 can inhibit PMCA
33 and SERCA
34
activity.
When extracellular Ca
2+ was raised to 1Æ2 mmol L
)1, the
[Ca
2+]i peak generated by the application of exogenous nuc-
leotides was followed by an elevated plateau. Importantly,
addition of Mn
2+ to the medium after UTP stimulation led to
quenching of the Fluo-4 signal (data not shown), indicating
that under these conditions UTP activated Ca
2+ entry. In con-
trast to extracellular nucleotides, LPA stimulation did not
produce an elevated Ca
2+ plateau in keratinocytes even in the
presence of millimolar levels of [Ca
2+]o (Fig. 4b). The reason
LPA fails to activate ACE in these cells is unclear but studies
on Jurkat T cells and a lung ﬁbroblast cell line also found that
LPA did not induce Ca
2+ entry in these cells.
27,28 Thus it
appears that despite its ability to mobilize Ca
2+ from internal
stores, LPA does not promote robust Ca
2+ entry in several dis-
tinct cell types. The contrast between UTP and LPA induced
[Ca
2+]i mobilization may be due to differential coupling of
LPA receptor activation to STIM1 or Orai1⁄CRACM1, two
newly discovered mediators of SOCE.
35–38 Indeed we have
observed that although both UTP and LPA evoke translocation
of STIM1 to the PM, the duration of STIM1 localization to the
PM is signiﬁcantly shorter in LPA treated cells.
39
In conclusion, the work presented here demonstrates that
extracellular nucleotides trigger Ca
2+ release in cultured
human keratinocytes, and when external Ca
2+ is in the milli-
molar range, Ca
2+ release follows sustained ACE. Stimulation
with LPA also evoked Ca
2+ release, but without inducing
robust Ca
2+ inﬂux. Pharmacological inhibition of iPLA2
impaired ACE, highlighting the importance of iPLA2 in ACE in
keratinocytes.
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